Ingqwalaselo yePolymyositis

I-Polymyositis ixhomekeke kwiqela elikhulu lezifo ezibizwa ngokuba yi-Myositis

I-polymyositis yindlela yokuqhaqhaqhaqhazelayo, isifo esiqhaqhazelayo, esinobukhulu obuthathaka. Inxalenye yesigaba sesifo esibizwa ngokuba yi-myositis, oku kuthetha ukuvuvukala kwemisipha. I-polymyositis ichaphazela izihlunu eziseduze nomthi womzimba, kodwa emva kwexesha ezinye izihlunu zingabandakanyeka. Ngokuqhelekileyo, i-polymyositis ikhula ngokuthe ngcembe, kwaye ngelixa ingahlakulela kunoma ubani, kubandakanywa nabantwana, ayinakuchaphazela abantu abangaphantsi kweminyaka eyi-18 ubudala.

Ngokuqhelekileyo, ichaphazela abantu abaneminyaka engama-40 no-60 ubudala. I-polymyositis ithinta abafazi abaninzi ngokuqhelekileyo kunamadoda, ngokulinganisa kabini ukuya komnye.

I-Dermatomyositis yimeko efanayo yokuvuvukala kwi-polymyositis, umahluko ukuba i-dermatomyositis ichaphazela ulusu. I-polymyositis iyakwenzeka ngokudibanisa kunye neengqungquthela ezithile, kuquka i- lymphoma , umdlavuza webele , umhlaza wamaphaphu, umdlavuza we- ovari , kunye nomhlaza wekoloni . I-polymyositis inokuvela kwezinye izifo ze-rheumatic, njenge- systemic sclerosis (scleroderma), izifo ezixubileyo zezifo , isifo se-rheumatoid , i- systemic lupus erythematosus kunye ne- sarcoidosis .

Isizathu sePolymyositis

Nangona kubangelwa ukuba i-polymyositis ingaziwa, kubonakala ngathi ukuzalwa kwindalo. Abaphengululi bakholelwa ukuba ukuphendula ngokuzenzekelayo kwintsikelelo kubonakala kubantu abanomdla wokuzalwa. I-subtrapes ye-HLA -DR3, -DR52, kunye ne -DR6 ibonakala idibaniswa kunye nokuxhomekeka.

Kusenokuba nesiganeko esichukumisayo, mhlawumbi i-myositis yentsholongwane okanye umdlavuza okhona ngaphambili.

Iimpawu zePolymyositis

Ubuthakathaka obuthathaka, njengoko kukhankanywe ngasentla, sisona sibonakaliso esivamile. Ubuthakathaka obuthathaka obunxulumene ne-polymyositis bunokuqhubeka kwiiveki okanye kwiinyanga. Ngokomzekelo weMerck Manual, ukutshabalaliswa kweepesenti ezingama-50 zeemfusibisi ze-muscle kubangela ubuthathaka obonakalisa, oko kuthetha, ngelo xesha i-myositis iphambili.

Ubunzima obuqhelekileyo obusebenzayo kunye ne-polymyositis kuquka ukunyuka esihlalweni, ukunyuka kwamanyathelo, nokuphakamisa iingalo. Ubuthathaka bemisipha yamabhinqa kunye nemigxala yamabhinqa kunokubangela ukulala okanye ukubopha ngevili. Ukuba kukho imisipha yentamo, kunokuba kunzima ukuphakamisa intloko yakho kwi-pillow. Ukubandakanya izihlunu ze-pharyngeal kunye neesophageal kunokuchaphazela ukugwinya. Okuthakazelisayo, izihlunu zezandla, iinyawo kunye nobuso azibandakanyi kwi-polymyositis.

Kukho ukubandakanyeka ngokubambisana okubonakala ngathi i-polyarthralgia okanye i- polyarthritis . Oku kuya kuphuhliswa kwi-subset yezigulane ze-polymyositis ezine-Jo-1 okanye ezinye i-anti-anthynthetase antibodies.

Ezinye iimpawu ezinxulumene ne-polymyositis zingaquka:

Ukuxilongwa kwePolymyositis

Njengoko naluphi na isifo okanye imeko, ugqirha uya kuqwalasela imbali yakho yezobugqirha kwaye enze uvavanyo olupheleleyo lomzimba njengenxalenye yenkqubo yokuxilonga. Iimvavanyo zegazi ziyakuthi zenziwe ukuba zikhangele ubukho be-antibodies ezizodwa kwaye zibone ukuvuvukala okungekho. I-Electromyography kunye neemvavanyo zokuqhutyelwa kwamagulane anganika ugqirha ngolwazi oluxhamlayo lokuxilonga, naye.

I-MRI yezihlunu ezichaphazelekayo iyalelwe. Ukongezelela, uvavanyo lomchamo luya kuhlola i-myoglobin, iprotheni kumaseli e-muscle ekhutshelwe kwigazi kwaye ihlanjwe ziintso xa i-muscle ibonakele. Iimvavanyo zegazi ukujonga izinga leenzyme ze-serum, ezifana neCK kunye ne-aldolase, zinokuyalelwa kwaye zenziwe. Ngenxa yokulimala kwemisipha, amanqanaba e-enzyme e-muscle ehlala ephakamileyo. Olunye uvavanyo lwegazi, i- ANA (uvavanyo lwe-anti-nuclear antibody) , luthembele kuma-80 ekhulwini labantu abanepolymyositis.

Ekugqibeleni, i-biopsy muscle ingenziwa ukuze kuqinisekiswe ukuxilongwa kwe-polymyositis.

I-biopsy inconywa ngaphambi kokuba kuqalwe unyango ukuze ezinye izifo zentsundu zikhutshwe.

Unyango lwe-polymyositis

I-Corticosteroids kumaqondo aphezulu yindlela yokuqala yokwelapha i-polymyositis ukunciphisa ukuvuvukala kwiimisipha. Ukuba loo nto yodwa ayinelisekile, i- immunosuppressants ingafakwa kwirejimeni yonyango. Ama-immunosuppressants anokuqwalaselwa aquka i- methotrexate (i-Rheumatrex), i-azathioprine (Imuran), i-mycophenolate (i-CellCept), i-cyclophosphamide (i-Cytoxan), i- rituximab (i-Rituxan), i-cyclosporine (i-Sandimmune), kunye ne-IV immunoglobulin (IVIG).

I-polymyositis echaphazelekayo nomhlaza kaninzi ayithobeli i-corticosteroids. Ukususwa kwe-tumor, ukuba kunokwenzeka, kunokuncedisa kakhulu kumathambo ahlobene nomhlaza.

ILizwi

Ngonyango lokuqala lwe-polymyositis, ukuxolelwa kunokwenzeka. Umlinganiselo weminyaka emihlanu wokusinda kwabantu abadala abanepolymyositis, ngokwemiqulu yeMerck, iipesenti ezingama-75-80. Ukufa kungabangelwa yimiphumo yobuthakathaka obunzima obuqhubekayo. Abantu abanesifo sengqondo okanye ukubandakanyeka kwepmonta kubonakala benesifo esibi ngakumbi. Oko kungathiwa ngezilwanyana ze-polymyositis ezine-cancer.

Ukuhlolwa kwentsholongwane kunconywa kwizigulane ze-polymyositis ezineminyaka engama-60 nangaphezulu. Khawukhumbule imfuno yohlolo lomhlaza rhoqo. Ukufumana umhlaza ongasetyenziswanga unokuba ngumphambili wokutshintsha isigxina sakho nge-polymyositis.

> Imithombo:

> Ikliniki yaseCleveland, i-Polymyositis, http://my.clevelandclinic.org/health/articles/polymyositis. Ukuhlaziywa kukaSept 2015.

> Hajj-ali, RA., MD. I-Polymyositis kunye neDermatomyositis. Manual Merck. Version Professional. Ukuhlaziywa / Ukuhlaziywa ngoJuni 2013.

> MedlinePlus, Polymyositis - Abadala. Ukuhlaziywa nguGordon A. Starkebaum, MD. NgoJanuwari 20, 2015.

> Nagaraju K, et al. "Izifo ezivuthayo zoMzimba kunye namanye amaMyopathies." I-Kelley's Bookbook yeRheumatology. 2016.